Radiopharm Theranostics Limited (RDPTF) Net income 2023–2025
Radiopharm Theranostics Limited (RDPTF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$38.3MFY2025 · since FY2023: -$34.6M → -$38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.3M | +20.0% |
| FY2024 | -$47.9M | -38.5% |
| FY2023 | -$34.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RDPTF financial trends
RDPTF RevenueRDPTF Net marginRDPTF Gross profitRDPTF Gross marginRDPTF Operating incomeRDPTF Operating marginRDPTF Operating cash flowRDPTF Free cash flowRDPTF Capital expendituresRDPTF Return on equityRDPTF Stock buybacksRDPTF Dividends paidRDPTF Total assetsRDPTF Total liabilitiesRDPTF Shareholders’ equityRDPTF overview →